Page 4«..3456..1020..»

Category : Testosterone Physicians

Clarus Therapeutics Expands Executive Team in Preparation for Landmark Launch of JATENZO (testosterone undecanoate) Capsules CIII – GlobeNewswire

NORTHBROOK, Ill., Dec. 11, 2019 (GLOBE NEWSWIRE) -- Clarus Therapeutics, Inc. today announced the appointment of five senior leaders, each of whom bring valuable industry and category experience to the team. Together they strengthen the companys commercialization capability for JATENZO (testosterone undecanoate) capsules, the first-in-class oral testosterone replacement therapy approved by the U.S. Food and Drug Administration (FDA) for the treatment of hypogonadism. See indication and important risk information, including boxed warning below.

Dr. Newmark, Mr. Jaeger, Mr. Rodriguez, Ms. Wright and Mr. Holloway join a management team led by Robert Dudley, Ph.D., Clarus Therapeutics Chief Executive Officer and co-inventor of JATENZO. Dr. Dudleys legacy in mens health includes CEO leadership of the company that developed and launched AndroGel, a product he co-invented and the last major advancement in testosterone replacement therapy delivery.

We are proud to bring Jay, Frank, Jose, LaTonya, and James into an organization that shares their focus on innovation and excellence. They have each demonstrated an ability to connect with medical professionals who are invested in mens health, said Dudley. Their expertise will help us make the long sought-after oral testosterone option widely available to appropriate hypogonadal men.

INDICATION

JATENZO (testosterone undecanoate) capsules, CIII, is an androgen indicated for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone:

Limitation of use

Safety and efficacy of JATENZO in males less than 18 years old have not been established.

IMPORTANT SAFETY INFORMATION

WARNING: INCREASES IN BLOOD PRESSURE

CONTRAINDICATIONS

JATENZO is contraindicated in men with carcinoma of the breast or known or suspected carcinoma of the prostate, in women who are pregnant, in men with a known hypersensitivity to JATENZO or its ingredients, or in men with hypogonadal conditions that are not associated with structural or genetic etiologies as JATENZO has not been established for these conditions and there is a risk of increased blood pressure with JATENZO that can increase the risk of MACE.

WARNINGS AND PRECAUTIONS

ADVERSE EVENTS

The most common adverse events of JATENZO (incidence 2%) are headache (5%), increased hematocrit (5%), hypertension (4%), decreased HDL (3%), and nausea (2%).

DRUG INTERACTIONS

USE IN SPECIFIC POPULATIONS

The safety and efficacy of JATENZO in pediatric patients less than 18 years old have not been established. Improper use may result in acceleration of bone age and premature closure of epiphyses.

There have not been sufficient numbers of geriatric patients involved in controlled clinical studies utilizing JATENZO to determine whether efficacy or safety in those over 65 years of age differs from younger subjects. There is insufficient long-term safety data in geriatric patients utilizing JATENZO to assess the potentially increased risk of cardiovascular disease and prostate cancer.

Please see accompanying full Prescribing Information, including BOXED WARNING on increases in blood pressure.About JATENZO JATENZO is a first-in-class proprietary oral soft gel formulation of testosterone undecanoate for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone.

JATENZOs proprietary formulation is built around testosterone undecanoate a testosterone prodrug that the body converts to testosterone. In the JATENZO pivotal inTUne (investigation of its oralTestosteroneUndecanoate) clinical trial, 87% (n=222) of men treated with JATENZO achieved average circulating levels of testosterone in the normal range for men.

About Clarus Therapeutics, Inc.Clarus is a men's specialty pharmaceutical company developing and preparing for the commercial launch of JATENZO, a product protected by patents issued in the United States and in other major pharmaceutical markets around the world. Clarus owns the worldwide, royalty-free commercialization rights for JATENZO.For more information, please visit:www.clarustherapeutics.com.

Media ContactAmir KhanPhone: (212) 462-8767Email: Amir.Khan@Syneoshealth.com

2019 Clarus Therapeutics, Inc. All rights reserved.

Read the original:
Clarus Therapeutics Expands Executive Team in Preparation for Landmark Launch of JATENZO (testosterone undecanoate) Capsules CIII - GlobeNewswire

Recommendation and review posted by Alexandra Lee Anderson

Global Testosterone Replacement Therapy Market Growth Analysis, Forecasts to 2025 AbbVie, Endo International, Eli lilly, Pfizer, Actavis, Bayer,…

The comprehensive research study presented here is a smart interpretation on the Global Testosterone Replacement Therapy Market that describes significant aspects such as segmentation, competition and the regional analysis present in the report contains a bursting of geographical markets based on factors such as market share, CAGR, production, and consumption. Productivity and accuracy are two of the key features of the report that reflect its authenticity. The report authors have concentrated on Porters Five Forces analysis, SWOT analysis, and PESTLE analysis of the Testosterone Replacement Therapy market.

Furthermore, they have focused on qualitative and quantitative analyses to help with a broad understanding of the global Testosterone Replacement Therapy market. In addition, the report gives powerful suggestions and recommendations to help players to make vigorous development procedures and guarantee amazing deals in the global Testosterone Replacement Therapy market. The global Testosterone Replacement Therapy market is esteemed at a million US$ in 2018 is expected to reach a million US$ by the end of 2025, growing at a CAGR of during 2019-2025.

Access PDF version of this Report with and consultation!https://marketinsights.biz/23982/#Request-Sample

The Top Leading players operating in the market, Covered in this Report: AbbVie, Endo International, Eli lilly, Pfizer, Actavis (Allergan), Bayer, Novartis, Teva, Mylan, Upsher-Smith, Ferring Pharmaceuticals, Kyowa Kirin, Acerus Pharmaceuticals & More.

The report provides a comprehensive analysis of the competitive landscape including thorough company profiling of top players operating in the global Testosterone Replacement Therapy market. Readers are given an accurate outlook of the global Testosterone Replacement Therapy market, which incorporates carefully calculated revenue and volume growth, CAGR, and market share estimations. The report provides precisely prepared statistics that display the comparison of the previously mentioned estimations for all years of the forecast period.

Market StructureThe report contains each and every single edge in market structure analysis to demonstrate how various segments of the global Testosterone Replacement Therapy market are developing in terms of production, consumption, revenue, volume, and other important factors. The analysts have segmented the global Testosterone Replacement Therapy market by region, product, and application.

By the product type, the market is primarily split into:Gels, Injections, Patches, Other

By the end-users/application, this report covers the following segments:Hospitals, Clinics, Others

Regional Segmentation: North America (United States, Mexico, and Canada) Europe (France, Germany, UK, Russia, and Italy) Asia-Pacific (Japan, China, Korea, India, and South-east Asia) South America (Colombia, Brazil, Argentina, etc.) Middle East and Africa (UAE, Saudi Arabia, Egypt, Nigeria, and South Africa)

Grab Your Report at an Impressive Discount! Please click Here@https://marketinsights.biz/23982/#Buying-Inquiry

This Strategic Points Covered in TOC:

Chapter 1: Introduction, market overview, market risk and opportunities, market driving forces, product scope of the global market

Chapter 2: Assessing the top manufacturers of the global Testosterone Replacement Therapy market which consists of its sales, price, and revenue of the products

Chapter 3: Showing the competitive nature among key players, with market share, revenue, and sales

Chapter 4: Introducing global Testosterone Replacement Therapy market by regions, market share and with sales and revenue for the projected period

Chapter 5, 6, 7, 8 and 9: To assess the market by manufacturers, by segments and by countries with revenue share and sales by key countries in these different regions

What will the report include?

Market Dynamics: The report shares significant data on market drivers, impact factors, opportunities, challenges, and Testosterone Replacement Therapy market trends as a feature of market dynamics.

Regional Market Research: It could be separated into two various sections: one for regional production analysis and the other for regional consumption analysis. Here, the research offers revenue, price, gross margin, production, CAGR, and other factors that show the development of all regional markets studied in the report.

Global Market Forecast: Readers are given with revenue and production forecasts for the global Testosterone Replacement Therapy market, production and consumption forecasts for regional markets, production, revenue, and price forecasts for the global Testosterone Replacement Therapy market by type, and consumption forecast for the global Testosterone Replacement Therapy market by application.

Market Rivalry: In this segment, the report gives data on competitive scenarios and trends including merger and acquisition and expansion, market shares of the top three or five players, and market focus rate. Perusers could also be furnished with revenue, production, and average price shares by manufacturers.

For a full view of the report details, Reports TOC, Figure and Tables, Click@https://marketinsights.biz/23982/global-testosterone-replacement-therapy-market-2018-2025-industry-research-report-key-players-status-analysis-outlook-segmentation-and-forecast/

Research MethodologyReports supervise uses reliable primary and secondary research sources to assemble its reports. It additionally depends on the most recent research techniques to get ready highly detailed and accurate research analyses such as this one here. It uses data triangulation, tops down and bottoms up methodologies, and advanced research processes to come out with extensive and industry-best Testosterone Replacement Therapy market research reports.

Sorry! The Author has not filled his profile.

Go here to see the original:
Global Testosterone Replacement Therapy Market Growth Analysis, Forecasts to 2025 AbbVie, Endo International, Eli lilly, Pfizer, Actavis, Bayer,...

Recommendation and review posted by Alexandra Lee Anderson

Testosterone Replacement Therapy Market Top Players (Endo International, AbbVie, Eli lilly, Pfizer, Actavis, Bayer, Novartis, Teva, Mylan,…

Testosterone Replacement Therapy market report considers the present scenario of the Lawful Interception Industry and its market dynamics for the period 20192024. It covers a detailed overview of various market growth enablers, restraints, and trends. The study includes both the demand and supply sides of the market. It also profiles and analyzes the leading companies and several other prominent companies operating in the Testosterone Replacement Therapy market.

Get Sample Copy of this Reporthttps://www.orianresearch.com/request-sample/1150984

Summary

Testosterone replacement therapy (TRT) is a class of hormone replacement therapy in which androgens, often testosterone, are replaced. Testosterone replacement therapy (TRT) is an FDA-approved medical treatment for men of any age who have low testosterone, a hormone necessary for male sexual development.

The report forecast global Testosterone Replacement Therapy market to grow to reach xxx Million USD in 2019 with a CAGR of xx% during the period 2020-2024.

The report offers detailed coverage of Testosterone Replacement Therapy industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Testosterone Replacement Therapy by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

First, this report covers the present status and the future prospects of the global Testosterone Replacement Therapy market for 2015-2024.And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].

At the same time, we classify Testosterone Replacement Therapy according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.

Finally, the report provides detailed profile and data information analysis of leading Testosterone Replacement Therapy Company.

Following Key Companies are analyzed in this Report :- Endo International AbbVie Eli lilly Pfizer Actavis (Allergan) Bayer Novartis Teva Mylan Upsher-Smith Ferring Pharmaceuticals Kyowa Kirin Acerus Pharmaceuticals

Inquire more or share questions if any on this report @https://www.orianresearch.com/enquiry-before-buying/1150984

Key Content of Chapters as follows (Including and can be customized) :

Part 1:Market Overview, Development, and Segment by Type, Application & Region

Part 2:Company information, Sales, Cost, Margin etc.

Part 3:Global Market by company, Type, Application & Geography

Part 4:Asia-Pacific Market by Type, Application & Geography

Part 5:Europe Market by Type, Application & Geography

Part 6:North America Market by Type, Application & Geography

Part 7:South America Market by Type, Application & Geography

Part 8:Middle East & Africa Market by Type, Application & Geography

Part 9:Market Features

Part 10:Investment Opportunity

Part 11:Conclusion

Order a copy of Testosterone Replacement Therapy Market Report 2019 @https://www.orianresearch.com/checkout/1150984

Market Segment as follows:

By RegionAsia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]North America[United States, Canada, Mexico]Middle East & Africa[GCC, North Africa, South Africa]South America[Brazil, Argentina, Columbia, Chile, Peru]

Contact Us:Ruwin MendezVice President Global Sales & Partner RelationsOrian Research ConsultantsUS: +1 (832) 380-8827 | UK: +44 0161-818-8027Email: [emailprotected]Website:www.orianresearch.com/Follow Us on LinkedIn:https://www.linkedin.com/company-beta/13281002/

About Us:Orian Research is one of the most comprehensive collections of market intelligence reports on the World Wide Web. Our reports repository boasts of over 500000+ industry and country research reports from over 100 top publishers. We continuously update our repository so as to provide our clients easy access to the worlds most complete and current database of expert insights on global industries, companies, and products. We also specialize in custom research in situations where our syndicate research offerings do not meet the specific requirements of our esteemed clients.

Read more here:
Testosterone Replacement Therapy Market Top Players (Endo International, AbbVie, Eli lilly, Pfizer, Actavis, Bayer, Novartis, Teva, Mylan,...

Recommendation and review posted by Alexandra Lee Anderson

Testosterone Replacement Therapy Market Size by Type, Product, Application & Market Opportunities 2019-2024 – Progressive Arkansas | Arkansas’…

Testosterone Replacement Therapy Market Outlook provides thoughtful analysis of current issues facing the industry, along with current facts and statistics about the production and application in Testosterone Replacement Therapy Market.. The Testosterone Replacement Therapy market is expected to grow at a CAGR of over XX% during the period 20192024.

The global Testosterone Replacement Therapy market has been subjected to several regulatory compliances and crucial coding terminology over the years. Adherence to regulatory standards remains crucial for vendors.

The study considers the present scenario of the Testosterone Replacement Therapy market and its market dynamics for the period 20192024. It covers a detailed overview of several market growth enablers, restraints, and trends. The report covers both the demand and supply aspect of the market. This research report on the Testosterone Replacement Therapy market covers sizing and forecast, market share, industry trends, growth drivers, and vendor analysis.

Read Report Details at https://www.proaxivereports.com/59211

The competitive environment in the Testosterone Replacement Therapy market is intensifying. The market currently witnesses the presence of several major as well as other prominent vendors, contributing toward the market growth. However, the market is observing an influx of local vendors entering the market.

The study profiles and examines leading companies and other prominent companies operating in the Testosterone Replacement Therapy industry.

List of key players profiled in the report:

AbbVieEndo InternationalEli lillyPfizerActavis (Allergan)BayerNovartisTevaMylanUpsher-SmithFerring PharmaceuticalsKyowa KirinAcerus Pharmaceuticals

Request for Sample Report athttps://www.proaxivereports.com/request-sample/59211

TheTestosterone Replacement TherapyMarket Segmentation:

Product Type SegmentationGelsInjectionsPatches

Industry SegmentationHospitalsClinics

Channel (Direct Sales, Distributor) Segmentation

Vendors can consider targeting key regions such as APAC, North America, and Europe to gather maximum customer attention. Countries in the APAC region such as China, India, and Japan among others are expected to display significant growth prospects in the future due to high economic growth forecasts along with huge population statistics leading to high consumption of goods and products.

Ask more details or request custom reports to our experts athttps://www.proaxivereports.com/pre-order/59211

Testosterone Replacement Therapy Market segmentation by region:

The changing regulatory compliance scenario and the growing purchasing power among consumers are likely to promise well for the North America market. New product development and technological advancements remain key for competitors to capitalize upon in the Testosterone Replacement Therapy industry across the globe.

Purchase Testosterone Replacement Therapy Market Report athttps://www.proaxivereports.com/checkout/59211

Key Market Insights:

The report provides the following insights into the Testosterone Replacement Therapy market for the forecast period 20192024.

Post Views: 27

See the original post here:
Testosterone Replacement Therapy Market Size by Type, Product, Application & Market Opportunities 2019-2024 - Progressive Arkansas | Arkansas'...

Recommendation and review posted by Alexandra Lee Anderson

Are you ready for testosterone replacement therapy – KTAR.com

Are you ready for testosterone replacement therapy?

It is well known that testosterone plays a role in a mans sex drive, but this vital hormone does more than regulate libido and sperm production. It also has a role in regulating systems throughout the body.

It also affects bone and muscle mass, the way men store fat in the body, and even red blood cell production, according to Healthline. A mans testosterone levels can also affect his mood.

Symptoms of declining testosterone

Testosterone production maxes out in most men around age 17, and then levels stay relatively consistent for the next 10 to 20 years. Sometime between ages 30 and 40, its normal for men to experience a slow decline in testosterone production, averaging about 1% a year, according to Harvard Health.

You lose muscle mass, mental sharpness and libido (sex drive) begins to decline, viTal4men says.

Benefits of testosterone

Research has pinpointed other links between testosterone levels and memory. One study cited by Harvard Health found that World War II veterans who had high testosterone levels in midlife had better preserved tissue in some parts of the brain later in life.

Another study found that men with higher free testosterone levels achieved higher scores on four cognitive function tests, including visual and verbal memory, according to Harvard Health.

Testosterone replacement therapy aims to address the symptoms men experience from low testosterone levels and possibly help protect cognitive function in later life.

You may benefit from testosterone replacement therapy if any of the following apply:

Treatment options

The proper method of testosterone delivery for you is a matter for your physician to determine; however, many find that some gels tend to be messy and less convenient than other treatment modalities, viTal4men says.

These are typical treatment options, according to Harvard Health:

Most men feel improvement in symptoms within four to six weeks of taking testosterone replacement therapy, although changes like increases in muscle mass may take from three to six months, Harvard Health says.

Work with your doctor to find out whether you are experiencing symptoms of low testosterone. Misuse of testosterone can be dangerous, and injections should be administered only by healthcare professionals. Suddenly stopping testosterone treatment can also cause unpleasant withdrawal symptoms, according to drugs.com.

Schedule a free testosterone level test at vital4men.com, and find out if testosterone replacement therapy is right for you.

View post:
Are you ready for testosterone replacement therapy - KTAR.com

Recommendation and review posted by Alexandra Lee Anderson

Global Testosterone Replacement Therapy Market is Expected to Generate Huge Acquisition by 2029 – Trade Examiner

The Fundamentals of Testosterone Replacement Therapy Market explains the demand drivers, geographical distribution, and competitive scenario of the market for the forecast period 2020-2029. The industry report on testosterone replacement therapy market outlines and studies the preeminent competitors, also presents the insights with the important industry analysis of the key factors impacting the market dynamics. The report presents the potential of the market and the predictive figures that are required to work for the duration period of 2020 to 2029.

In addition to all this, insights covering Testosterone Replacement Therapy market dynamics and competitive scenario, feasibility study, industry boundaries, latest strategies, and tactics are explained in this study. The forecast period is 2020-2029 where utilization estimate, advertise worth and volume are available. An underlying part of the study also maps the significant factors associated with recent events such as mergers and acquisitions, collaboration and new product launches. The report offers a holistic summary of the Testosterone Replacement Therapy Market with the help of application segments and geographical regions(United States, Europe, China, Japan, Southeast Asia, India, Central & South America, ROW) that govern the market currently. The information with respect to a portion of the predominant players-AbbVie,Endo International,Eli lilly,Pfizer,Actavis (Allergan),Bayer,Novartis,Teva,Mylan,Upsher-Smith,Ferring Pharmaceuticals,Kyowa Kirin,Acerus Pharmaceuticals

For Sample Report Request Here (Use official eMail ID to Get Higher Priority): https://market.us/report/testosterone-replacement-therapy-market/request-sample

The research covers market performance assessment, in which different segments are evaluated in accordance with their market size, growth rate, and overall appeal. The report offers a comprehensive and intelligent analysis of the competition, segmentation, dynamics, and geographical advancement of the Global Testosterone Replacement Therapy Market. It takes into account the CAGR, value, volume, revenue, production, consumption, sales, manufacturing cost, prices, and other key factors related to the global testosterone replacement therapy market.

Testosterone Replacement Therapy Market: Key players

AbbVieEndo InternationalEli lillyPfizerActavis (Allergan)BayerNovartisTevaMylanUpsher-SmithFerring PharmaceuticalsKyowa KirinAcerus Pharmaceuticals

Testosterone Replacement Therapy Market Segment by Type covers:

GelsInjectionsPatches

Testosterone Replacement Therapy Market Segment by Applications can be divided into:

HospitalsClinics

Regional analysis covers:

Center East and Africa Testosterone Replacement Therapy Market (Saudi Arabia, UAE, Egypt, Nigeria, South Africa)

North America Testosterone Replacement Therapy Market (United States, Canada, Mexico)

Asia Pacific Testosterone Replacement Therapy Market (China, Japan, Korea, India, Southeast Asia)

South America Testosterone Replacement Therapy Market (Brazil, Argentina, Colombia)

Europe Testosterone Replacement Therapy Market (Germany, UK, France, Russia, Italy)

To Get Instant Access, Purchase Report Here: https://market.us/purchase-report/?report_id=18112

Key Reasons for buying this report:

To understand the most influencing driving and restraining forces in testosterone replacement therapy market 2020 to 2029 and its impact in the worldwide market.

It also provides custom research according to particular testosterone replacement therapy requirements With Primary And Secondary Research Methodologies

Survey for testosterone replacement therapy creation forms, serious issues, and solutions for moderate the improvement hazard.

To obtain insightful summaries Testosterone Replacement Therapy Market 2020 to 2029 and have a complete understanding of the global and its commercial landscape.

The expected market growth and development status can be understood in a better way through this ten-year forecast information presented in this report.

Enquire regarding this analysis report (Use Corporate Details Only): https://market.us/report/testosterone-replacement-therapy-market/#inquiry

Global Testosterone Replacement Therapy Market TOC (Table Of Content) Provides Following Market Segment:

Segment 1 Study Coverage

Segment 2 Executive Summary

Segment 3 Testosterone Replacement Therapy Market Size by Manufacturers

Segment 4 Production by Regions

Segment 5 Consumption by Regions

Segment 6 Testosterone Replacement Therapy Market Size by Type

Segment 7 Testosterone Replacement Therapy Market Size by Application

Segment 8 Manufacturers Profiles

Segment 9 Production Forecasts

Segment 10 Consumption Forecast

Segment 11 Upstream, Industry Chain and Downstream Customers Analysis

Segment 12 Threat and Affecting Factors, Opportunities & Challenges

Segment 13 Key Findings

Segment 14 Appendix

View Detailed Report with Respective Tables and Figures:https://market.us/report/testosterone-replacement-therapy-market/

About Us:Market.us offers its clients a one-stop solution platform for all market research needs. Our focus on custom research, consulting projects, syndicate reports covers a variety of industries, sectors, and verticals, and we cover niche market titles, and we also cater to client-specific requirements. Analysts at Market.us have access to large databases of statistical information, Customs Import and Export Database, Industry Association Database, etc., besides expert resources and participants. Our expert panel includes specialists in industries and sectors such as energy, automotive, chemicals, healthcare, medical, ICT consumer goods, banking & finance, mining & minerals, food and beverages, agriculture and other related fields, aerospace, machinery & equipment, etc., apart from professional survey teams and competent teams of data analysts and researchers.

Get in Touch with Us :

Mr. Benni Johnson

Market.us (Powered By Prudour Pvt. Ltd.)

Send Email: inquiry@market.us

Address: 420 Lexington Avenue, Suite 300 New York City, NY 10170, United States

Tel: +1 718 618 4351

Website: https://market.us

See more here:
Global Testosterone Replacement Therapy Market is Expected to Generate Huge Acquisition by 2029 - Trade Examiner

Recommendation and review posted by Alexandra Lee Anderson

Testosterone injections: Uses, safety, and side effects – Medical News Today

Testosterone injections are hormone treatments. Their primary use is as a treatment for sexual dysfunction in males and postmenopausal symptoms in females with a testosterone deficiency. Transgender men and nonbinary people may also use testosterone injections as part of masculinizing therapy.

Testosterone injections are safe for many people, but they can have side effects. The side effects may be different depending on the reason why the person is using the injections.

Although testosterone injections can help for low testosterone due to medical conditions, the Food and Drug Administration (FDA) do not recommend using testosterone to treat natural aging-related testosterone changes as it may increase the risk of certain health issues.

Keep reading for more information on testosterone injections, including their uses, safety, and potential side effects.

Testosterone injections are injections of isolated testosterone. This hormone is present in both males and females, but the levels are naturally higher in males.

Testosterone therapy is becoming more common in the United States. Before recommending long-term testosterone therapy, doctors should make sure that the person understands and has weighed up the risks and benefits.

The following sections look at the uses of testosterone injections.

Doctors may recommend testosterone injections to treat males with low testosterone levels. Low testosterone production by the testicles is called hypogonadism.

Low testosterone can have negative effects. The symptoms of low testosterone in males include a lower sperm count, a decrease in bone or muscle mass, increased body fat, and erectile dysfunction. Normal total testosterone levels in the bloodstream in healthy adult males are 2801,100 nanograms per deciliter (ng/dl).

When treating hypogonadism, testosterone therapy can have the following benefits:

It is important to note that this therapy treats the symptoms of low testosterone rather than the underlying cause.

Anyone who suspects that they may have low testosterone can see a doctor for a diagnosis. However, the symptoms are quite general and could be due to other conditions or lifestyle factors.

Not all males with low testosterone will need treatment, and it is not always safe. The FDA have approved testosterone replacement therapy only for males with low testosterone due to disorders of the testicles, brain, or pituitary gland and not for natural age-related declines.

Read about other ways to increase testosterone levels and eight foods that may increase testosterone here.

Testosterone therapy is more controversial in females than in males.

Normal total testosterone levels in healthy adult females are 1570 ng/dl. Low testosterone in females can cause fertility problems, irregular periods, vaginal dryness, and a low sex drive. Despite this, doctors do not often recommend testosterone injections to treat low testosterone in females, as they can have masculinizing effects.

However, doctors may recommend testosterone therapy to help with hypoactive sexual desire disorder in females after menopause. Research has not supported their use for other signs and symptoms that people may experience after menopause, which include anxiety, mood changes, weight gain, and reduced bone density.

Currently, the FDA have not approved any products for testosterone therapy in females. Additionally, in the USA, there are no readily available formulations that provide the recommended treatment dose of 300 micrograms per day for females. As a result, a female will typically need a compounding pharmacy to fill the prescription.

Testosterone therapy allows people to develop a more masculine appearance. Transgender men, nonbinary people, and other individuals may choose to use testosterone injections as part of a gender transition. This use of testosterone injections is known as masculinizing hormone therapy.

Testosterone therapy helps a person develop male sexual characteristics and reduce female characteristics, and it can lead to any of the following changes:

These testosterone therapy regimens are similar to those that treat hypogonadism in males. Taking testosterone injections once a week may be the best way to keep the levels of this hormone even.

Testosterone injections can come in several varieties. These include:

When a person receives a testosterone injection, the hormone directly enters the body through the muscle. People can choose between two methods:

When having testosterone injections, people will usually visit their doctor every few months for monitoring. Treatments could last for a lifetime or be short-term, depending on the individual's circumstances.

Testosterone injections may be safe for many people when they follow a doctor's instructions. However, research has also linked testosterone therapy with several side effects and possible complications.

Possible negative effects of testosterone therapy may include:

Some people may have an allergic reaction to testosterone injections. For example, testosterone undecanoate may cause a serious allergic reaction or breathing issues following the injection. Symptoms can include breathing problems, dizziness, and skin rashes.

Other forms of testosterone, including testosterone enanthate, may increase blood pressure, which can raise the risk of a stroke or heart attack.

People who have had strokes, heart attacks, heart disease, or high blood pressure should make the doctor aware of this before starting testosterone injections, as they may have a higher risk of complications.

If someone experiences any of the following symptoms after a testosterone injection, they should seek emergency medical attention:

If a doctor prescribes male testosterone injections to an adolescent to treat a constitutional delay of growth and puberty, the goal will be to achieve an accelerated growth spurt during puberty. This therapy should not affect the final adult height that the adolescent reaches.

People may experience some mild side effects from testosterone injections, such as:

A person should speak to their doctor if they experience more serious side effects, such as:

Doctors may prescribe testosterone injections to treat low testosterone due to certain medical conditions in males. It does not cure the underlying condition, but it may help alleviate some of the symptoms. People can also use these injections to treat sexual dysfunction resulting from bodily changes after menopause or as part of masculinizing hormone therapy.

People should be aware of the possible serious complications of using testosterone in both the short-term and long-term. Doctors should do a thorough evaluation and, if testosterone replacement therapy is an option, discuss the benefit and risks with the person before prescribing it.

It is important to follow a doctor's instructions at all times to reduce any risks.

Go here to see the original:
Testosterone injections: Uses, safety, and side effects - Medical News Today

Recommendation and review posted by Alexandra Lee Anderson

Testosterone: What It Can And Can’t Do, Signs You’re Low, And How To Increase It – Men’s Health

Feeling tapped out? Foggy? Just not all that into sex? Gotta be your testosterone, some people would have you believe. And were believing it, too, with interest and investment in T-boosters and T-supplements rising steadily in the past decade.

Dont get us wrong: testosterone is one critical hormone. Babies first encounter it in utero, when it triggers the differentiation of boys from girls. In puberty, it contributes to your bone growth and muscle mass, and continues to affect functions including your red-blood-cell production and mood stability.

But the message certain vested interests are sending plays right into the economic and social anxieties men are facing. Its like when anti anxiety meds such as Valium first came onto the scene, says urologist Elizabeth Kavaler. All these middle-aged women were addicted to Valium, because that was the solution to everything. Testosterone has become the new answer for a life of quiet desperation. More and more of us are feeling the exhaustion of uneasiness. We are being asked to do more with less. Were just trying to get through the day alive. Men think, Well, if I just get a little testosterone, Im going to feel great! Kavaler says. And thats not the case.

Theres so much information out there about T much of it speculation and lore that leads us to jump to conclusions about it. Men put all kinds of psychological weight on their testosterone number a low one makes you think youre somehow less manly; a high one means youre basically LeBron James and thats where we get things wrong. Theres little evidence for those stereotypes. Low doesnt automatically imply youre weak or retiring; high doesnt guarantee you muscles or MVP athletic performance.

A low number might not even be a low number for very long. It might just indicate that you havent been treating yourself very well. A high number doesnt mean youre programmed to be aggressive. As long as your T is in the normal range, theres nothing about a high number thats better than a low one, or vice versa. In the name of science and good journalism, I got my testosterone tested twice while writing this story.

It put my assumptions up against a pretty big test, too. What do you really know about this famous hormone? Here, we break down the best and latest information to give you the clearest picture yet of what T means for you.

IT CAN...

BUT TOO MUCH ALSO CAN...

IT CANT...

BUT IT ALSO CANT...

You should have at least two blood tests, since T is constantly in flux. It peaks in the morning, so if youre young and on a typical sleeping schedule, aim to be tested by 10am. If youre over 50, it doesnt matter as much. Also note: vitamins with biotin can lower your score, so skip them for three days before testing.

A T level of 8.64 to 29 nanomoles per litre of blood is considered normal. If you are close to 8.64 and you feel fine, then youre no less healthy than a guy whose level is 35 and also feels fine. Theres an exception to that, though. (See What the Numbers Mean.)

I got my first test at the tail end of a busy week. Id slept less than five hours the night before, then scrambled to the phlebotomist in a daze. My number: 9.9. Thats in the normal range, but just barely. I have no symptoms of low T, but it was hard to shake the feeling that there was something wrong with me, even though I know that normal is normal, no matter where it is in that range. Eleven days later, I was tested again. My number was 14.8. Why such a dramatic change? It might be because Id slept better and cut out my multivitamins. Irrational or not, I felt like more of a man. The whole experience was a microcosm of our relationship with T. We act like its destiny, but its just biology easily misunderstood and more varied than we think.

Common symptoms of below-normal t, which could affect as many as 500,000 men in Australia (generally older men):

1. Lack of energy

Youre lethargic not like you didnt get enough sleep last night but like no matter what you do, you never feel rested.

2. A paunch

Having a dad bod doesnt mean you have low T but it could be one indicator.

3. Lack of libido

Sort of. Its the lack of your base level sex drive that sudden feeling of being turned on by the sexy person you spot on the street that indicates low T, according to Dr Tobias Kohler, of the Mayo Clinic. Its not considered low libido when you dont want to have sex on a Thursday night after youve been crushed by work all week.

4. Erectile problems

Only precipitously low T will keep you limp. But if you have problems getting it up, you may have other issues to solve, which may require a visit to a doctor. Or a little blue pill. Or couples therapy

If your t is truly low youve got three courses of action, says mills, in order of increasing aggressiveness. choose wisely.

1. Lifestyle Adjustment

The single best thing you can do to improve your level is be healthier. Avoid stress, get more sleep and lose weight an enzyme in fat tissue converts testosterone to estrogen. Thats one reason flab can lower your T. Its also why overweight guys can develop man boobs, and why bodybuilders who juice can also develop man boobs they dont have much fat, but theyve jacked their T levels so high that theres a lot of it available to be turned into estrogen. Thinking of T strictly as the male sex hormone oversimplifies the complex hormonal interactions that make our bodies work. Which is also why, if you can avoid it, you dont want to go with the needle-in-the-butt routine to raise your T.

2. A Testicle Stimulant (plus lifestyle adjustment)

If your level is low enough to warrant more aggressive treatment, your doctor can prescribe a drug that causes your pituitary to tell your gonads to make more testosterone. The typical choice is clomiphene citrate (Clomid), a common fertility drug for women. Using it doesnt exempt you from needing to get healthy, though, as it doesnt diminish the risk of losing T to bad sleep and a beer belly.

3. Testosterone Replacement Therapy (and yes, youll still need to adjust your lifestyle)

This should be your last resort. When you give your body T, it stops making its own, and theres no guarantee it can start again. Before you replace it, find a doctor who can help you choose from the following delivery systems (see right), and be glad that weve moved past the early days of replacement therapies, like one in the 1920s that involved transplanting goat testicles into men.

Here is the original post:
Testosterone: What It Can And Can't Do, Signs You're Low, And How To Increase It - Men's Health

Recommendation and review posted by Alexandra Lee Anderson

Bragar Eagel & Squire, PC Reminds Investors That Class Action Lawsuits Have Been Filed Against Plantronics, Lipocine, Armstrong Flooring, and…

NEW YORK, Dec. 04, 2019 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder law firm, reminds investors that class action lawsuits have been commenced on behalf of stockholders of Plantronics, Inc. (NYSE: PLT), Lipocine, Inc. (NASDAQ: LPCN), Armstrong Flooring, Inc (NYSE: AFI), and Wanda Sports Group Company Limited (NASDAQ: WSG). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.

Plantronics, Inc. (NYSE: PLT)

Class Period: July 2, 2018 to November 5, 2019

Lead Plaintiff Deadline: January 13, 2020

On November 5, 2019, the Company disclosed a $65 million reduction in channel inventory by reducing sales to channel partners and decreased its fiscal 2020 guidance, expecting revenue between $1.72 billion and $1.81 billion and adjusted EBITDA between $282 million and $323 million. Plantronics also reported that its Executive Vice President of Global Sales was leaving the Company.

On this news, the Companys stock price fell $14.44 per share, or nearly 37%, to close at $25.00 per share on November 6, 2019.

The complaint, filed on November 13, 2019, alleges that throughout the Class Period defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Companys business, operations, and prospects. Specifically, defendants failed to disclose to investors: (1) that the Company had engaged in channel stuffing to artificially boost sales; (2) that the Companys internal control over inventory levels was not effective; (3) that the Company had not adequately monitored inventory levels ahead of multiple product launches, where the new models would displace demand for aging products; and (4) that, as a result of the foregoing, defendants positive statements about the Companys business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

For more information on the Plantronics class action go to: https://bespc.com/plt

Lipocine, Inc. (NASDAQ: LPCN)

Class Period: March 27, 2019 to November 8, 2019

Lead Plaintiff Deadline: January 14, 2020

Lipocines lead product candidate is TLANDO (LPCN 1021), an oral testosterone replacement therapy. The Company has previously submitted New Drug Applications (NDA) for TLANDO twice and, both times, received Complete Response Letters (CRL) from the U.S. Food and Drug Administration (FDA) rejecting the NDAs. The Company received the first CRL in June 2016 and the second in May 2018.

On March 27, 2019, Lipocine issued a press release announcing new topline results from a study evaluating TLANDOs effects on blood pressure (one issue cited by the FDA in a prior CRL rejecting TLANDOs NDA), as well as the Companys intention to refile the NDA for TLANDO in the second quarter of 2019.

On November 11, 2019, Lipocine issued a press release announcing receipt of a CRL from the FDA regarding its NDA for TLANDO. In the press release, Lipocine advised investors that the FDA had again rejected the NDA for TLANDOthis time because an efficacy trial had not met three of its secondary endpoints.

On this news, Lipocines stock price fell $1.93 per share, or 70.7%, to close at $0.80 per share on November 11, 2019.

The Complaint, filed on November 14, 2019, alleges that throughout the Class Period defendants made materially false and misleading statements regarding the Companys business, operational and compliance policies. Specifically, defendants made false and/or misleading statements and/or failed to disclose that: (i) the results from Lipocines clinical studies of TLANDO were insufficient to demonstrate the drugs efficacy; (ii) accordingly, Lipocines third NDA for TLANDO was highly likely to be found deficient by the FDA; and (iii) as a result, the Companys public statements were materially false and misleading at all relevant times.

For more information on the Lipocine class action go to: https://bespc.com/lpcn

Armstrong Flooring, Inc. (NYSE: AFI)

Class Period: March 6, 2018 to November 4, 2019

Lead Plaintiff Deadline: January 14, 2020

On May 3, 2019, Armstrong Floorings Chief Executive Officer abruptly resigned.

On this news, the Companys stock price fell $1.75, nearly 12%, to close at $13.14 per share on May 3, 2019.

Then, on November 5, 2019, Armstrong Flooring reported $165.6 million net sales for third quarter 2019, a nearly 21% decline year-over-year, and a net loss of $31.4 million. The Company also cut its full year 2019 guidance for adjusted EBITDA to a range of $20 million to $25 million, from prior guidance range of $46 million to $54 million, citing larger distributor movements on inventory than anticipated.

On this news, the Companys stock price fell $2.90 per share, or nearly 44%, to close at $3.70 per share on November 5, 2019.

The complaint, filed on November 15, 2019, alleges that throughout the Class Period defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Companys business, operations, and prospects. Specifically, defendants failed to disclose to investors: (1) that the Company had engaged in channel stuffing to artificially boost sales; (2) that the Companys internal control over inventory levels was not effective; and (3) that, as a result of the foregoing, defendants positive statements about the Companys business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

For more information on the Armstrong Flooring class action go to: https://bespc.com/afi

Wanda Sports Group Company Limited (NASDAQ: WSG)

Class Period: Securities purchased pursuant and/or traceable to the registration statement and related prospectus (collectively, the "Registration Statement") issued in connection with Wanda Sports July 26, 2019 initial public offering (IPO).

Lead Plaintiff Deadline: January 17, 2020

In July 2019, Wanda Sports held its IPO, issuing approximately 23.8 million American Depository Shares (ADSs) at $8.00 per share, pursuant to the Registration Statement. Wanda Sports shares have lost nearly 60% of their value, closing at $2.78 on November 18, 2019.

The complaint, filed on November 18, 2019, alleges that defendants made statements that were materially false and/or misleading because they misrepresented and failed to disclose the following adverse facts pertaining to the Companys business, operations and prospects: (1) the lack of major sporting events for its DPSS and Spectator Sports segments for its second quarter of 2019, ending before the IPO, would negatively impact revenue for the second quarter of 2019; (2) Wanda Sports had suffered a year-over-year decrease in revenue in its second quarter ended June 30, 2019 and would for its fiscal year 2019, primarily related to lower reimbursement revenues accounted for in its DPSS segment and lack of Spectator Sport segment offsets; and (3) as a result, defendants statements about the Companys business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

For more information on the Wanda Sports class action go to: https://bespc.com/wsg

About Bragar Eagel & Squire, P.C.:Bragar Eagel & Squire, P.C. is a nationally recognized law firm with offices in New York and California. The firm represents individual and institutional investors in commercial, securities, derivative, and other complex litigation in state and federal courts across the country. For more information about the firm, please visit http://www.bespc.com. Attorney advertising. Prior results do not guarantee similar outcomes.

Contact Information:Bragar Eagel & Squire, P.C.Brandon Walker, Esq.Melissa Fortunato, Esq.(212) 355-4648investigations@bespc.comwww.bespc.com

Read this article:
Bragar Eagel & Squire, PC Reminds Investors That Class Action Lawsuits Have Been Filed Against Plantronics, Lipocine, Armstrong Flooring, and...

Recommendation and review posted by Alexandra Lee Anderson

Testosterone Replacement Therapy Market Share, Size 2019 Global Industry Analysis, Development, Future Growth, Top Manufacture, Revenue,…

Global Testosterone Replacement Therapy Market Research Report comprises holistic business information and changing trends in the market that enables users to spot the pin-point analysis of the market along with revenue, growth, and profit during the forecast period 2019-2024. It provides an in-depth study of the Testosterone Replacement Therapy market by using a SWOT analysis. This gives a complete analysis of drivers, restraints, and opportunities of the market.

Additionally, the Testosterone Replacement Therapy report provides an in-depth study of prime players at intervals the market by lightness their product description, business summary, and business strategy. It also endows with the quantity of production, Testosterone Replacement Therapy future demand, required raw material, and the money health of the organization.

Request a sample of this report at https://www.acquiremarketresearch.com/sample-request/229964/

Top prominent Players: AbbVie, Endo International, Eli lilly, Pfizer, Actavis (Allergan), Bayer, Novartis, Teva, Mylan, Upsher-Smith, Ferring Pharmaceuticals, Kyowa Kirin, Acerus Pharmaceuticals

By the Product-Types, it primarily split into: Gels, Injections, Patches

By End-Users/Application, this report covers: Hospitals, Clinics

Based on segmentation, the global Testosterone Replacement Therapy market report is made up of in-depth investigation of the leading regions, including North America, China, and Rest of Asia-Pacific, UK, Europe, Central & South America, and Middle East & Africa. The Testosterone Replacement Therapy research was provided for, including developments, leading growth status, landscape analysis, and segmentation with product types and applications.

Get Discount with this Report at https://www.acquiremarketresearch.com/discount-request/229964/

Reasons to Buy

1. To gain insightful analyses of the Testosterone Replacement Therapy Systems market from 2019 to 2024 and have a comprehensive understanding of the global market and its commercial landscape.2. To assess the production processes, Testosterone Replacement Therapy major issues, and solutions to mitigate the development risk.3. To understand the most affecting driving and restraining forces in the Testosterone Replacement Therapy Systems market from 2019 to 2024 and its impact in the global market.4. To understand the future outlook and prospects for the Testosterone Replacement Therapy Systems market from 2019 to 2024.

The report additionally focuses on international major leading trade players of the world Testosterone Replacement Therapy market providing data like company profiles, product image, and specification, price, capacity, cost, production, revenue and call data.

Upstream raw materials and instrumentality and downstream demand analysis are additionally administrated. With tables and figures helping analyze the worldwide Testosterone Replacement Therapy market, this research provides Testosterone Replacement Therapy statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

Customization of this Report: This Testosterone Replacement Therapy report could be customized to the customers requirements. Please contact our sales professional [emailprotected], we will ensure you obtain the report which works for your needs.

See the article here:
Testosterone Replacement Therapy Market Share, Size 2019 Global Industry Analysis, Development, Future Growth, Top Manufacture, Revenue,...

Recommendation and review posted by Alexandra Lee Anderson


Page 4«..3456..1020..»